These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 16341176

  • 1. One drug tackles two diseases.
    Br Dent J; 2005 Dec 10; 199(11):701. PubMed ID: 16341176
    [No Abstract] [Full Text] [Related]

  • 2. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar 12; 151(11):46-7. PubMed ID: 19469206
    [No Abstract] [Full Text] [Related]

  • 3. [Men also need bone protection].
    MMW Fortschr Med; 2006 Nov 16; 148(46):48-9. PubMed ID: 17615790
    [No Abstract] [Full Text] [Related]

  • 4. [What do we need to know--what can we do?].
    Krankenpfl J; 2005 Nov 16; 43(7-10):217. PubMed ID: 16515289
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?].
    Thomas T, Reach G, Lespessailles E.
    Rev Prat; 2006 Jan 16; Spec No():3-11. PubMed ID: 16502833
    [No Abstract] [Full Text] [Related]

  • 8. [Risedronate (Actonel)--from randomized clinical trials to real life].
    Anić B.
    Reumatizam; 2007 Jan 16; 54(2):85-6. PubMed ID: 18351152
    [No Abstract] [Full Text] [Related]

  • 9. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar 27; 145(13):60. PubMed ID: 15101545
    [No Abstract] [Full Text] [Related]

  • 10. [Patient compliance program aids therapy success].
    MMW Fortschr Med; 2009 Mar 12; 151(11):47. PubMed ID: 19469207
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention].
    MMW Fortschr Med; 2004 Aug 05; 146(31-32):53. PubMed ID: 15529718
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug 05; 17(96):143. PubMed ID: 19480098
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.